Rates of CAR T-cell–related toxicities, CRS, and ICANS in patients with R/R CNS B-ALL stratified by CNS disease grade and presence of radiological evidence and/or symptoms
Toxicity/Grade . | CNS status . | Radiological evidence and/or symptoms . | ||
---|---|---|---|---|
CNS-2 (n = 15) . | CNS-3 (n = 16) . | Yes (n = 7) . | No (n = 24) . | |
CRS, n (%) | ||||
Grade 3/4 | 0 (0) | 1 (6.3) | 0 (0) | 1 (4.2) |
All grades | 13 (86.7) | 10 (62.5) | 7 (100) | 16 (66.7) |
ICANS, n (%) | ||||
Grade 3/4 | 4 (26.7) | 7 (43.7) | 6 (85.7) | 5 (20.8) |
All grades | 9 (60.0) | 11 (68.8) | 7 (100) | 13 (54.1) |
Toxicity/Grade . | CNS status . | Radiological evidence and/or symptoms . | ||
---|---|---|---|---|
CNS-2 (n = 15) . | CNS-3 (n = 16) . | Yes (n = 7) . | No (n = 24) . | |
CRS, n (%) | ||||
Grade 3/4 | 0 (0) | 1 (6.3) | 0 (0) | 1 (4.2) |
All grades | 13 (86.7) | 10 (62.5) | 7 (100) | 16 (66.7) |
ICANS, n (%) | ||||
Grade 3/4 | 4 (26.7) | 7 (43.7) | 6 (85.7) | 5 (20.8) |
All grades | 9 (60.0) | 11 (68.8) | 7 (100) | 13 (54.1) |